The ruling blocks Lupin and Zydus Life from selling their generic version of Mirabegron, the bioequivalent of Astellas' ...

But understanding the causes of these disorders and how to stop them has remained elusive. Researchers have now learned more about a major trigger of immune activity, and how it may relate to ...